Frequently Asked Questions (FAQs)
- What is the National Hospital Price Transparency Study?
- How will round 6 be different from previous rounds?
- How is the Study funded?
- Can I see reports from previous rounds?
- How do I sign up to participate?
- How much does it cost for employers to participate?
- What information will the private reports provide?
- What agreements need to be in place for a self-funded employer to participate?
- How will RAND ensure data security and privacy of protected health information (PHI)?
- What is RAND?
- Who can I contact for more information?
- Does this study fall in the antitrust "safety" zone?
- What is the potential timeline for Round 6?
- Will employers and insurers be identified?
- Will the claims data be shared outside RAND or sold to third parties?
What is the National Hospital Price Transparency Study?
The National Hospital Price Transparency Study is an ongoing effort to measure and publicly report the prices paid for hospital care. Using actual claims data, the initiative publicly compares hospital prices at the hospital- and service-line level, the first effort of its kind and scale.
Core goals:
- Enable employers to be better-informed shoppers for health plans and provider networks
- Report hospital prices relative to a Medicare benchmark
RAND designs and conducts the studies, recruits participants, and prepares all reports and supplemental materials
How will Round 6 be different from previous rounds?
The Study has expanded significantly since Round 1, a pilot codeveloped with the Employers Forum of Indiana (EFI) that analyzed 120 Indiana hospitals' prices using 2013–2016 claims data from approximately a dozen self-funded employers. Round 2 expanded to 1,598 hospitals across 25 states (2015–2017 data). Rounds 3, 4, and 5 further expanded coverage to 49 states, excluding Maryland (2016–2018, 2018–2020, and 2020–2022 data respectively).
Round 6 focuses on 2023–2025 data and expands data collection from additional contributors, including more all-payer claims databases (APCDs) and employers.
How is the Study funded?
The Study is funded through a combination of foundation grants and contributions from participating employers.
- Round 1 was fully funded by The Robert Wood Johnson Foundation (RWJF).
- Round 2 was funded by RWJF, the National Institute for Health Care Reform, The Health Foundation of Greater Indianapolis, and participating self-funded employers.
- Rounds 3, 4, 5 were funded by RWJF and participating self-funded employers.
- Round 6 is funded by Arnold Ventures and participating self-funded employers.
No funding from hospitals or from health plans is accepted.
Can I see reports from previous rounds?
Yes. Reports and supplemental material (data, methodology, and detailed findings) are freely available:
- Round 1: https://www.rand.org/pubs/research_reports/RR2106.html/
- Round 2: https://www.rand.org/pubs/research_reports/RR3033.html
- Round 3: https://www.rand.org/pubs/research_reports/RR4394.html
- Round 4: https://www.rand.org/pubs/research_reports/RRA1144-1.html
- Round 5: https://www.rand.org/pubs/research_reports/RRA1144-2-v2.html
How do I sign up to participate?
Self-funded employers, health plans, business coalitions, all-payer-claim-databases (APCDs), and other organizations that have employer hospital claims databases are welcome to participate.
To express interest (with no commitment): visit our Contact Us page or email Brian Briscombe at bbriscom@rand.org.
How much does it cost for employers to participate?
Self-funded employers can participate in two ways
- Funding participants: Contribute $0.20[1] per covered life (minimum $1,000, maximum $15,000) and receive a customized private report showing the prices they paid to each hospital relative to average prices paid to those same hospitals.
- Data only participants: Provide claims data at no cost but do not receive a private report.
Fully-insured health plans and all payer claims databases (APCDs) are data only participants. All claims data from participants will be included in the public report.
What information will the private reports provide?
Private reports include:
- Total allowed amounts paid to all hospitals for inpatient and outpatient care, and for facility and professional care, as a percent of what Medicare would have paid for the same services from the same hospitals
- Total amounts paid per service for hospital care relative to Medicare, and relative to average commercial rates
- Allowed amounts paid to individual hospitals and hospital systems (identified by name) relative to Medicare reimbursement
For an example of the tables and figures in a private report, contact Brian Briscombe (bbriscom@rand.org).
What agreements need to be in place for a self-funded employer to participate?
The process depends on whether RAND already has a Data Use Agreement (DUA) in place with your Third Party Administrator (TPA) or data warehouse.
- If RAND already has a DUA with your TPA: No additional agreements are required. Simply inform your TPA that your self-funded employer wishes to participate, and they will provide you with instructions on how to proceed. Sometimes the TPA will require a simple data release form, and occasionally a data release fee.
- If RAND does NOT have a DUA in place with your TPA: A new DUA must be drafted and signed. RAND provides a draft DUA for these situations. Typically, the self-funded employer asks the TPA to review the draft DUA, then the TPA signs, followed by the employer and RAND.
- If your claims data is with a data warehouse: The process is sometimes as simple as instructing your data warehouse to release your 2023-2025 claims data to RAND. Some data warehouses may require a written agreement before releasing the data.
RAND actively guides you through the process. To explore further or view RAND's draft DUA, contact Brian Briscombe (bbriscom@rand.org).
How will RAND ensure data security and privacy of protected health information (PHI)?
As defined under the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule, protected health information (PHI) refers to information that identifies an individual and that relates to the individual's medical conditions or health care services[2]. Health insurers, health care providers, and employers that self-fund their health plans are all considered “covered entities,” and are, therefore, subject to the HIPAA Privacy Rule, meaning that they must take safeguards to maintain the privacy of PHI.
RAND will enter into DUAs with the TPAs and any other suppliers of claims data, and those DUAs will obligate RAND to adhere to HIPAA privacy standards. The DUAs will specify a data safeguarding plan for protecting privacy of PHI, including physical access controls, network security, and a process for securely deleting PHI once it is no longer needed for the study.
In general, RAND will avoid receiving any data elements that are unnecessary for the study or that could be used to directly identify patients, and RAND will erase data containing PHI as soon as those data have been processed and are no longer necessary. RAND will also limit publication of results based on the number of data points available. For example, hospital-specific prices will only be reported if a minimum number of 11 claims are available.
TPAs and other data suppliers will create extracts of their claims data that will contain the minimum fields necessary for the study. Those raw claims data will not include direct identifiers (e.g. patient names or medical record numbers) but they will identify the employer and will include detailed information (including dates of service) on health care services. Employer identifiers, when combined with the health and medical records of their employees, are considered PHI because they could, in small firms, be linked to individual employees. Because service dates and employer identifiers are included in the raw claims data, those data must be considered PHI even though direct identifiers are not included.
The TPAs and other data suppliers will transmit the PHI either by secure file transfer protocol (SFTP) or by encrypted drive. Once RAND receives the raw claims data, it will be loaded onto a secure workstation and the SFTP files and encrypted drive will be securely erased.
RAND analysts will then create two derivative files. The first derivative file will be a deidentified claims dataset that excludes service dates (except for year) and excludes employer identifiers and thereby satisfies the HIPAA safe harbor standard for deidentification. The second file will be an employer-claim link file that only includes two fields: a unique identifier for each claim and a unique identifier for each employer.
The deidentified claims dataset will reside on a secure RAND server. RAND analysts will go through the process of repricing the claims using Medicare's payment formulas, resulting in a deidentified dataset containing actual allowed amounts from the raw claims data in addition to simulated Medicare payment amounts. RAND will then produce aggregated price data summaries for the public report.
To produce employer-specific reports, RAND will use the deidentified claims data with Medicare prices. Those claims data will then be merged with the employer-claim link file to produce a dataset containing claims data with actual allowed amounts, simulated Medicare payment amounts, and employer identifiers. That claims dataset will then be processed to create employer-specific summarized price data, which is summary data that includes employer identifiers but will not include any individual-level health records and therefore will not include PHI.
What is RAND?
RAND develops solutions to public policy challenges, helping communities become safer, more secure, healthier, and more prosperous. RAND is nonprofit, nonpartisan, and committed to the public interest.
RAND's mission is to help improve policy and decisionmaking through research and analysis. RAND experts apply advanced methods from a variety of fields to address a broad range of issues—including national security, health, education, and technology.
Learn More About RANDWho can I contact for more information?
Contact Brian Briscombe at bbriscom@rand.org.
Does this study fall in the antitrust “safety” zone?
The Federal Trade Commission (FTC) and the U.S. Department of Justice (DOJ) share responsibility for monitoring mergers and anti-competitive behavior and protecting consumer interests through enforcement of antitrust law. The FTC and DOJ in 1996 released guidance describing their general approach to antitrust enforcement in the health care industries[3], and the FTC and DOJ have issued more-recent guidance relating specifically to Accountable Care Organizations[4] and to the public disclosure of contracts between health plans and providers[5].
Hospitals and health systems would put themselves in legal jeopardy with the FTC and DOJ if they engaged in private exchanges of information regarding prices and costs for anticompetitive purposes (“price fixing”). The FTC and DOJ recognize, however, the potential benefits of public exchanges of health care price and cost information, and they have defined a “safety zone” for such exchanges. Those exchanges will not be challenged if “(1) the survey is managed by a third-party, … (2) the information provided by survey recipients is based on data more than 3 months old; and (3) there are at least five providers' reported data upon which each disseminated statistic is based, no individual provider's data represents more than 25 percent on a weighted basis of that statistics, and any information disseminated is sufficiently aggregated such that it would not allow recipients to identify the prices charged or compensation paid by any particular provider[6].”
This study satisfies conditions (1) and (2) for the safety zone, but not condition (3)—the reporting of hospital-specific prices falls outside the safety zone. But, as the FTC and DOJ make clear, “public, non-provider initiated surveys may not raise competitive concerns,” as long as they are “for procompetitive purposes.” The current study, given that it is initiated and supported by employers in their role as purchasers of health care, is clearly procompetitive in its intent, execution, and impact.
The Center for Improving Value in Health Care (CIVHC), the not-for-profit organization that administers Colorado's all payer claims database, analyzes and publicly reports provider-specific price and cost data similar to the public price reports that will result from this study. CIVHC has shared a legal opinion supporting those exchanges, with the key takeaway being that public reports, even if they fall outside the safety zone, are generally permissible “unless competitor recipients of the reports used the information to enter into price-fixing agreements[7].”
What is the potential timeline for Round 6?
Round 6 follows this timeline, with public results expected in September 2027:
- November 2025: Begin recruitment of self-funded employers, APCDs, and health plans. Amend agreements with organizations that participated in the previous round(s).
- June 2026: All agreements and DUAs in place between RAND and employers, health plans, APCDs, and data warehouses. All authorizations sent by self-funded employers to their TPAs and data warehouses. Data transfers begin.
- June 2026 through November 20, 2026: Transfer claims data to RAND.
- November 20, 2026: All data delivery complete. Begin data testing and analysis, drafting of public report.
- December 2026 through August 2027: Clean and analyze claims data, draft public report, submit report to RAND quality assurance process (QA).
- September 2027: Public report finalized and made public online.
- September through December 2027: Private employer-level reports produced and distributed.
RAND will work with all participants to meet these milestones. Questions about the timeline? Contact Brian Briscombe at bbriscom@rand.org.
Will employers and insurers be identified?
No. The public reports do not identify participating self-funded employers, health plans, or TPAs that provide claims data. Each private report is only shared with that specific employer.
Will the claims data be shared outside RAND or sold to third parties?
No. Data use agreements specify that only RAND may receive the data. Data use is limited to preparing the public report, private reports, and potential follow-on studies conducted by RAND using standardized and fully deidentified extracts of the claims data.
RAND will not retain any PHI beyond the publication date of the public report. RAND will not transmit or sell the claims data or data extracts to third parties.
References
- For example, an employer with 1,000 covered lives would contribute $1,000, an employer with 10,000 covered lives would contribute $2,000, and a mega-employer with 75,000 lives or more would contribute the maximum of $15,000. Return to content ⤴
- U.S. Department of Health and Human Services, Guidance Regarding Methods for De-identification of Protected Health Information in Accordance with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (PDF), November 26, 2012. Return to content ⤴
- U.S. Department of Justice, and Federal Trade Commission, Statements of Antitrust Enforcement Policy in Health Care, August, 1996. Return to content ⤴
- Federal Trade Commission, and Department of Justice, “Statement of Antitrust Enforcement Policy Regarding Accountable Care Organizations Participating in the Medicare Shared Savings Program; Notice (PDF),” Federal Register, Vol. 76, No. 209, October 28, 2011. Return to content ⤴
- Federal Trade Commission, Amendments to the Minnesota Government Data Practices Act Regarding Health Care Contract Data (PDF), June 29, 2015. Return to content ⤴
- U.S. DOJ and FTC, 1996, p. 50. Return to content ⤴
- Center for Improving Value in Health Care, Antitrust Legality of Reports and Analytic Data Sets Generated Based on All Payer Claims Data (PDF), 2014. Return to content ⤴